COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 805: Articles 8041-8050  | Next

Argon plasma-modified bacterial cellulose filters for protection against respiratory pathogens
Zywicka, A., Ciecholewska-Jusko, D., Szymanska, M., Drozd, R., Sobolewski, P., Junka, A., Gorgieva, S., El Fray, M., Fijalkowski, K.
10.1101/2022.04.28.489859 — Posted: 2022-04-29
Occupational differences in SARS-CoV-2 infection: Analysis of the UK ONS Coronavirus (COVID-19) Infection Survey
Rhodes, S., Wilkinson, J., Pearce, N., Mueller, W., Cherrie, M., Stocking, K., Gittins, M., Katikireddi, S. V., van Tongeren, M.
10.1101/2022.04.28.22273177 — Posted: 2022-04-29
A bacteriophage-based, highly efficacious, needle and adjuvant-free, mucosal COVID-19 vaccine
Zhu, J., Jain, S., Sha, J., Batra, H., Ananthaswamy, N., Kilgore, P. B., Hendrix, E., Hosakote, Y. M., Wu, X., Olano, J. P., Kayode, A., Galindo, C. L., Banga, S., Drelich, A., Tat, V., Tseng, C.-T. K., Chopra, A. K., Rao, V. B.
10.1101/2022.04.28.489809 — Posted: 2022-04-29
PCR Testing in the UK During the SARS-CoV-2 Pandemic - Evidence from FOI Requests
Jefferson, T., Dietrich, M., Brassey, J., Heneghan, C.
10.1101/2022.04.28.22274341 — Posted: 2022-04-29
Systematic analysis of alternative splicing in time course data using Spycone
Lio, C. T., Louadi, Z., Fenn, A., Baumbach, J., Kacprowski, T., List, M., Tsoy, O.
10.1101/2022.04.28.489857 — Posted: 2022-04-29
A Novel Y-Shaped, S-O-N-O-S-Bridged Crosslink between Three Residues C22, C44, and K61 Is a Redox Switch of the SARS-CoV-2 Main Protease
Yang, K. S., Kuo, S.-T. A., Blankenship, L. R., Sheng, Y. J., Sankaran, B., Li, P., Fierkee, C. A., Russell, D. H., Yan, X., Xu, S., Liu, W. R.
10.1101/2022.04.29.490044 — Posted: 2022-04-29
Clinical Features and Outcomes of COVID-19 at a Teaching Hospital in Kingston, Jamaica
Thompson, T. K., Dawkins, Y., Rowe-Gardener, S., Chin-Harty, L., Hoe, K. K., Ehikhametalor, K., Ferguson, T. S., Gordon-Johnson, K.-A., Deyde, V.
10.1101/2022.04.27.22274270 — Posted: 2022-04-29
Protection against Omicron re-infection conferred by prior heterologous SARS-CoV-2 infection, with and without mRNA vaccination
Carazo, S., Skowronski, D. M., Brisson, M., Sauvageau, C., Brousseau, N., Gilca, R., Ouakki, M., Barkati, S., Fafard, J., Talbot, D., Gilca, V., Deceuninck, G., Garenc, C., Carignan, A., De Wals, P., De Serres, G.
10.1101/2022.04.29.22274455 — Posted: 2022-04-29
Understanding Definitions and Reporting of Deaths Attributed to COVID-19 in the UK - Evidence from FOI Requests
Jefferson, T., Dietrich, M., Brassey, J., Heneghan, C.
10.1101/2022.04.28.22274344 — Posted: 2022-04-29
A Solution to the Kermack and McKendrick Integro-Differential Equations
Duclos, T. G., Reichert, T. A.
10.1101/2022.04.28.22274442 — Posted: 2022-04-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).